abagovomab 26
abciximab 25
abituzumab 18
abrilumab 16
actoxumab 14
adalimumab 15
aducanumab 9
afasevikumab 16
alacizumab_pegol 11
alemtuzumab 22
alirocumab 17
amatuximab 33
andecaliximab 20
anifrolumab 20
anrukinzumab 16
aprutumab 12
aprutumab_ixadotin 12
arcitumomab 21
ascrinvacumab 6
atezolizumab 14
atinumab 12
avelumab 11
basiliximab 24
bavituximab 30
begelomab 22
benralizumab 22
bevacizumab_beta 15
bezlotoxumab 14
bimagrumab 10
bleselumab 11
blinatumomab 32
blosozumab 25
bococizumab 15
brazikumab 10
brentuximab_vedotin 20
briakinumab 15
brodalumab 6
brolucizumab 25
brontictuzumab 17
burosumab 14
cabiralizumab 17
camrelizumab 12
canakinumab 23
cantuzumab_ravtansin 40
carlumab 12
carotuximab 24
cergutuzumab_amunaleukin2 21
cergutuzumab_amunaleukin 21
certolizumab_pegol 21
cetiximab 35
citatuzumab_bogatox 24
cixutumumab 20
clivatuzumab_tetraxetan 15
codrituzumab 26
conatumumab 6
concizumab 28
crenezumab 16
crizanlizumab 19
crotedumab 16
dacetuzumab 18
daclizumab 10
dalotuzumab 32
dapirolizumab_pegol 23
daratumumab 13
dectrekumab 9
demcizumab 18
denosumab 10
depatuxizumab 17
depatuxizumab_mafodotin 17
dezamizumab 16
dinutuximab 33
diridavumab 13
domagrozumab 14
drozitumab 12
duligotuzumab 18
durvalumab 9
dusigitumab 8
efalizumab 27
efungumab 25
eldelumab 11
elezanumab 13
elgemtumab 8
elotuzumab 15
emactuzumab 16
emapalumab 22
emibetuzumab 11
enavatuzumab 23
enfortumab_vedotin 9
enoblituzumab 15
enokizumab 18
enoticumab 14
ensituximab 28
eptinezumab 17
erenumab 13
etaracizumab 17
etrolizumab 19
evinacumab 20
evolocumab 5
farletuzumab 12
fasinumab 18
fezakinumab 11
fibatuzumab 5
ficlatuzumab 14
firivumab 28
flanvotumab 14
fletikumab 16
foralumab 8
foravirumab 11
fremanezumab 24
fresolimumab 16
fulranumab 18
futuximab 17
galcanezumab 13
ganitumab 23
gantenerumab 10
gemetuzumab 22
gemtuzumab2 21
gemtuzumab 22
gevokizumab 19
girentuximab 23
glembatumumab 13
glembatumumab_vedotin 13
guselkumab 19
ibalizumab 22
ibritumomab 25
icrucumab 6
idarucizumab 23
ifabotuzumab 5
imalumab 14
imgatuzumab 15
inclacumab 10
indatuximab_ravtansin 27
indusatumab 12
inebilizumab 26
intetumumab 8
iodine_girentuximab 25
ipilimumab 3
iratumumab 9
isatuximab 32
itolizumab 22
ixekizumab 27
labetuzumab_govitecan 19
lambrolizumab 24
lampalizumab 20
lanadelumab 15
landogrozumab 16
laprituximab 21
lebrikizumab 33
lendalizumab 20
lenzilumab 11
lifastuzumab_vedotin 21
ligelizumab 21
lilotomab 33
lirilumab 14
lodelcizumab 10
lokivetmab 23
lorvotuzumab_mertansin 18
lucatumumab 25
lumretuzumab 12
lupartumab 7
lutikizumab 19
margetuximab 31
milatuzumab 31
mirvetuximab 30
mirvetuximab_soravtansin 30
modotuximab 30
mogamulizumab 28
monalizumab 15
motavizumab 26
moxetumomab_pasudotox 25
namilumab 11
naratuximab 23
naratuximab_emtansin 23
narnatumab 13
navicixizumab2 24
navicixizumab 19
navivumab 32
necitumumab 8
nemolizumab 19
nesvacumab 13
nivolumab 10
obiltoxaximab 18
obinutuzumab 30
ocaratuzumab 25
ofatumumab 13
olaratumab 12
olokizumab 21
omalizumab 17
onartuzumab 19
ontuxizumab 17
opicinumab 13
orticumab 9
otelixizumab 32
oxelumab 9
ozanezumab 24
pamrevlumab 6
panobacumab 17
parsatuzumab 20
pasotuxizumab 20
pateclizumab 13
patritumab 15
pembrolizumab 24
perakizumab 15
pidilizumab 18
pinatuzumab_vedotin 16
plozalizumab 26
pogalizumab 21
polatuzumab_vedotin 18
ponezumab 31
prezalumab 12
pritoxaximab 26
quilizumab 19
racotumomab 19
radretumab 13
ralpancizumab 18
ramucirumab 13
ranevetmab 17
ranibizumab 19
refanezumab 21
remtolumab 13
rilotumumab 12
rinucumab 15
risankizumab 33
rituximab 19
rivabazumab 13
robatumumab 19
roledumab 23
romosozumab 18
rontalizumab 19
rosmantuzumab 18
rozanolixizumab 16
sacituzumab 20
sacituzumab_govitecan 20
samalizumab 19
sapelizumab 20
sarilumab 11
secukinumab 9
seribantumab 14
setoxaximab 40
sifalimumab 7
siltuximab 23
simtuzumab 24
sirukumab 8
solanezumab 19
solitomab 17
stamulumab 13
suptavumab 14
suvizumab 16
tabalumab 9
tadocizumab 11
tamtuvetmab 29
tanezumab 20
tarextumab 8
tavolixizumab 15
telisotuzumab 25
teplizumab 16
tesidolumab 14
tezepelumab 19
tigatuzumab 16
tildrakizumab 18
timolumab 13
tisotumab 10
tosatoxumab 29
tositumomab 25
tralokinumab 20
trastuzumab 20
tregalizumab 23
trevogrumab 12
ublituximab 27
urelumab 15
ustekinumab 22
utomilumab 24
vadastuximab 21
vadastuximab_talirin 21
vandortuzumab_vedotin 10
vantictumab 17
vanucizumab2 15
vanucizumab 21
varlilumab 11
vatelizumab 17
vedolizumab 22
veltuzumab 13
vesencumab 11
vorsetuzumab 15
vorsetuzumab_mafodotin 15
vunakizumab 29
xentuzumab 15
zatuximab 30
